On this page
Our read
Formial Labs is likely to push into more clinics and pharmacies before seeking a larger seed round.
For operators
Formial Labs is taking prescription skincare into clinics and pharmacies, backed by a Rs 2.88 crore pre-seed, so pharmacy and beauty-retail operators should watch dermatologist-led ranges as a competing source of skincare demand.
Watch
Repeat-customer share above the 40% reported, by its next funding round, would mean clinic and pharmacy buyers are reordering, not trying once.
The report, : Formial Labs raises Rs 2.88 crore pre-seed led by Zeropearl VC to scale prescription skincare through clinics and pharmacies
Bengaluru-based Formial Labs has already distributed more than 5,000 formulations, and OZiva founder Aarti Gill took part in the round. The money will go towards expanding its clinical team and its formulations, alongside wider distribution.
- Pre-seed round
- Rs 2.88 crore
- Formulations distributed
- more than 5,000
- SKUs
- over 87
- Repeat customers share of business
- 40 per cent
One email each morning: the day’s top moves in Indian retail, why each matters and what to watch. Free. Stop any time.
Reported figures
From the report. Source details below
| SKUs: | over 87 |
|---|---|
| Month-on-month growth: | 40 per cent |
| Repeat customers share of business: | 40 per cent |
What to track next
- Count of clinics and pharmacies stocking Formial Labs, as disclosed
- SKU count against the 87-plus reported, and whether new lines are prescription-led
- Month-on-month growth holding near the 40% reported as the base grows